Cargando…

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation

SIMPLE SUMMARY: Aggressive neuroblastoma (NB) is one of the most common pediatric cancers and causes a disproportionate mortality among affected children. A better knowledge about the biology of this tumor is needed to be able to provide new treatments and prognostic tools. Protein kinases are one o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colmenero-Repiso, Ana, Gómez-Muñoz, María A., Rodríguez-Prieto, Ismael, Amador-Álvarez, Aida, Henrich, Kai-Oliver, Pascual-Vaca, Diego, Okonechnikov, Konstantin, Rivas, Eloy, Westermann, Frank, Pardal, Ricardo, Vega, Francisco M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699843/ https://www.ncbi.nlm.nih.gov/pubmed/33233777 http://dx.doi.org/10.3390/cancers12113465

Ejemplares similares

Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness
por: Gómez-Muñoz, María A., et al.
Publicado: (2023)

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma
por: Linares-Clemente, Pedro, et al.
Publicado: (2017)

A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines
por: Amador-Álvarez, Aida, et al.
Publicado: (2022)

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
por: Vega, Francisco M., et al.
Publicado: (2020)

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours
por: Vega, Francisco M., et al.
Publicado: (2019)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2
por: Vázquez-Cedeira, Marta, et al.
Publicado: (2011)

VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
por: Shields, Julie A., et al.
Publicado: (2022)

The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53
por: Valbuena, Alberto, et al.
Publicado: (2008)

Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer
por: Lee, Namgyu, et al.
Publicado: (2017)

Hypoxia in the Initiation and Progression of Neuroblastoma Tumours
por: Huertas-Castaño, Carlos, et al.
Publicado: (2019)

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
por: So, Jonathan, et al.
Publicado: (2022)

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
por: Afanasyeva, Elena A, et al.
Publicado: (2021)

Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities
por: Sanz-García, Marta, et al.
Publicado: (2008)

Autonomous pick-and-place using the dVRK
por: D’Ettorre, Claudia, et al.
Publicado: (2021)

VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1
por: Monte-Serrano, Eva, et al.
Publicado: (2023)

HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation
por: Ryu, Hye Guk, et al.
Publicado: (2021)

Functional characterization of lysosomal interaction of Akt with VRK2
por: Hirata, Noriyuki, et al.
Publicado: (2018)

Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways
por: Vinograd-Byk, Hadar, et al.
Publicado: (2018)

VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
por: Martín-Doncel, Elena, et al.
Publicado: (2019)

Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation
por: Moura, David S., et al.
Publicado: (2016)

Circular RNA VRK1 correlates with favourable prognosis, inhibits cell proliferation but promotes apoptosis in breast cancer
por: Li, Yang, et al.
Publicado: (2020)

DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
por: Carrión-Marchante, Rebeca, et al.
Publicado: (2021)

VRK-1 extends life span by activation of AMPK via phosphorylation
por: Park, Sangsoon, et al.
Publicado: (2020)

Data on the identification of VRK2 as a mediator of PD-1 function
por: Peled, Michael, et al.
Publicado: (2021)

Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo
por: Molitor, T P, et al.
Publicado: (2013)

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
por: Hartlieb, Sabine A., et al.
Publicado: (2021)

Effects of VRK2 (rs2312147) on White Matter Connectivity in Patients with Schizophrenia
por: Sohn, Hoyoung, et al.
Publicado: (2014)

Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia
por: Stoll, Marion, et al.
Publicado: (2016)

Adult-Onset Spinal Muscular Atrophy due to Mutations in the VRK1 Gene
por: Sung, Angela, et al.
Publicado: (2021)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome
por: Körber, Verena, et al.
Publicado: (2023)

Cell Proliferation in Neuroblastoma
por: Stafman, Laura L., et al.
Publicado: (2016)

Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway
por: Valbuena, Alberto, et al.
Publicado: (2011)

A novel VRK1 mutation associated with recessive distal hereditary motor neuropathy
por: Feng, Shu‐Yan, et al.
Publicado: (2018)

Novel alternatively-spliced exons of the VRK2 gene in mouse brain and microglial cells
por: Almarzooq, Salsabil, et al.
Publicado: (2020)

Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease
por: Yamaura, Genpei, et al.
Publicado: (2019)

Dissecting the roles of Haspin and VRK1 in histone H3 phosphorylation during mitosis
por: Cartwright, Tyrell N., et al.
Publicado: (2022)

A genome-wide RNAi screen for genes important for proliferation of cultured Drosophila cells at low temperature identifies the Ball/VRK protein kinase
por: Mendaluk, Anna, et al.
Publicado: (2023)

VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
por: Rodríguez-Hernández, Irene, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bos7lkj6nu8425gbpht61qu7nk